Investigational Agents

You are here

Investigational Agents

If you have been NEWLY DIAGNOSED  START HERE 

Video Library

ASCO Lung Cancer Roundtable - NSCLC - New Potential Treatments for MET and RET Positive NSCLC
We are happy to present the GRACE ASCO 2020 Lung Cancer Patient Education, News and Updates series. Dr. Jack West has a virtual discussion with...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
General Lung Cancer, Biopsy/Tissue Collection, Adjuvant Therapy, Chemotherapy, Tumor Marker Tests, Targeted Therapy, Molecular Testing, Non Small Cell Lung Cancer, Clinical Trials, Investigational Agents
ASCO Lung Cancer Roundtable - NSCLC - Enhertu and the Potential for Treatment of HER2 Positive NSCLC
We are happy to present the GRACE ASCO 2020 Lung Cancer Patient Education, News and Updates series. Dr. Jack West has a virtual discussion with...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
General Lung Cancer, Clinical Trials, Investigational Agents, Biopsy/Tissue Collection, Targeted Therapy, Molecular Testing, Non Small Cell Lung Cancer
,
,
,
,
2017 Advances in Immunotherapy: What Lung Cancer Patients Need to Know OncTalk
The Global Resource for Advancing Cancer Education (GRACE), in partnership with Georgetown University Hospital is pleased to present the videos from the panel discussion "2017 Advances in Immunotherapy: What Lung Cancer Patients Need to Know".
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Biopsy/Tissue Collection, Tumor Marker Tests, Targeted Therapy, First-line treatment, Clinical Trials, Investigational Agents, Immunotherapies, Second-line treatment
,
,
Targeted Therapies in Lung Cancer Patient Forum 2017 – It’s a Wrap!
On Saturday, September 16, 2017, patients, caregivers, family members and friends joined GRACE in Cleveland at the Taussig Cancer Center for a full...
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
General Lung Cancer, Targeted Therapy, Biopsy/Tissue Collection, Tumor Marker Tests, Molecular Testing, Clinical Trials, Investigational Agents
ASCO 2016 - J-ALEX Trial: Should Alecensa Replace Xalkori as first-Line ALK Therapy
GRACE is happy to present the 5th in our series ASCO 2016 Lung Cancer Roundtable , Highlights and New Approaches in Lung Cancer . Featuring Jack West...
Cancer Journey:
In Treatment, Just Diagnosed
Cancer Type:
Lung Cancer
Disease Learning:
Targeted Therapies – ALK, Investigational Agents

Articles

2017 Advances in Immunotherapy: What Lung Cancer Patients Need to Know
Download slides from LIVE WEBCAST of November 18, 2017 in partnership with Georgetown University Hospital, GRACE presents: 2017 Advances in Immunotherapy: What Lung Cancer Patients Need to Know
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Immunotherapies, Investigational Agents, Clinical Trials

Community Forum

Local Therapies for Metastatic Lung Cancer Who, What, Why, When and How?
Hi Grace Members, Grace is happy to present in partnership with the Swedish Cancer Institute " Local Therapies for Metastatic Lung Cancer Who,...
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Lung Cancer, Drugs, Targeted Therapies – ALK, Targeted Therapies - EGFR, Targeted Therapies – ROS1, Procedures & Treatments, Chemotherapy, Tumor Marker Tests, Targeted Therapy, Investigational Agents, Immunotherapies, Radiation Therapy, Non Small Cell Lung Cancer
Vaxira for stage 4 NSCLC
Has anyone any information on obtaining and using Vaxira, the Cuban drug, for stage 4 advanced NSCLC? Not sure if US citizens can still travel to...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
ANGIOGENESIS, 3rd Line and beyond, Targeted Therapy, Investigational Agents, Non Small Cell Lung Cancer